Infectious disease studies and vaccine development studies are diverse, dynamic and complex areas of research that require a thorough understanding of many different indications, as well as populations and environments, to create safe, effective therapies and vaccines. Due to the continuing evolution of new strains and re-emerging pathogens, the timing and seasonal preparedness can be critical.

Pharmaron’s specialist infectious disease team at our Phase l Clinical Research Center (CPC) in Maryland, U.S. have completed over 50 vaccine studies and have an in-depth understanding of the complexities of all types of vaccine trials. The team are committed to helping our clients make fast and accurate decisions about clinical development programs, while providing ongoing regulatory guidance.

Utilized controlled human infection models in studies include Campylobacter, Cryptosporidium, Cholera, Enterotoxigenic E coli, Norovirus and COVID.

Learn more about our experience across multiple vaccine development studies, challenges studies and site and subject safety by downloading our info sheet.